Dec 18 (Reuters) - Hologic Inc HOLX.O:
FDA: HOLOGIC REMOVES BIOZORB 3D BIOABSORBABLE MARKERS DUE TO RISK FOR PATIENT COMPLICATIONS
FDA: THERE HAVE BEEN 252 REPORTED INJURIES RELATED TO HOLOGIC'S BIOZORB 3D BIOABSORBABLE MARKERS
FDA: IDENTIFIED HOLOGIC'S RECALL AS MOST SERIOUS TYPE; RECALL INVOLVES REMOVING DEVICES FROM WHERE THEY ARE USED/SOLD
Source text: [ID:]
Further company coverage: HOLX.O
((Reuters.Briefs@thomsonreuters.com;))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。